An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate
Being an exploratory study, the findings of this substudy serve as potential avenues for further research.
Authors
- Kesheng Wang (ORCID: https://orcid.org/0000-0001-7118-3877)
- David B. Cluck (ORCID: https://orcid.org/0000-0003-3656-1144)
- Michelle M. Duffourc
- Sam Harirforoosh (ORCID: https://orcid.org/0000-0002-2631-3756)
- Stacy D. Brown (ORCID: https://orcid.org/0000-0001-5566-1728)
- Jonathan P. Moorman (ORCID: https://orcid.org/0000-0002-6102-6541)
- Benjamin C. Kennard
- Marine Bertoni
- Derek E. Murrell
Institutions
- East Tennessee State University (US)
- University of South Carolina (US)
- Chapman University (US)
Publication Details
- Journal
- Drugs in R&D
- Published
- 2025-05-25
- DOI
- https://doi.org/10.1007/s40268-025-00509-6
- Citations
- 1
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- East Tennessee State University
- Vanderbilt University
- Georgia Clinical and Translational Science Alliance
- National Institutes of Health
- National Center for Research Resources